Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
172.8 USD | +1.06% | +7.27% | -4.16% |
05-14 | BeiGene Highlights New Hematology Portfolio and Pipeline Data at EHA2024 | CI |
05-09 | Beigene Q1 Loss Shrinks as Revenue Grows; Company's Shares Nearly 7% Up | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.16% | 18.08B | |
+9.42% | 115B | |
+11.84% | 106B | |
-1.05% | 21.96B | |
-14.15% | 21.87B | |
-5.29% | 19.21B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B | |
-24.95% | 8.23B |
- Stock Market
- Equities
- BGNE Stock
- News BeiGene, Ltd.
- BeiGene : Cowen & Co. Adjusts Price Target on BeiGene to $429 From $348, Maintains Outperform Rating